{chelation therapy}

Search WWW Search ehealthandhealing.com

 

 Conditions ] Integrative Cancer Therapy ] [ Chelation Therapy ] Intravenous Therapy ]
 

Chelation Therapy: Is It Natural?


Leon Chaitow N.D., D.O., M.R.O.
Editor-in-Chief, Journal of Therapeutic Bodywork;
Senior lecturer, University of Westminster, London

How fast and how dramatically we age has a great deal to do with impaired circulatory efficiency. If arteries could be kept supple, prevented from hardening and narrowing, the free flow of blood would be assured and both the risk of a rapid degree of ageing as well as many diseases associated with age - such as forms of cardiovascular degeneration, athero- and arteriosclerosis, peripheral circulatory dysfunction, some types of kidney disease, hypertension, cerebrovascular accidents and premature senility as well as, in many instances, cirrhosis and kidney disease - could be prevented or significantly helped if they already existed.

Supporters of chelation therapy claim just these benefits and yet, despite the many published papers supporting these claims (see References), many doctors find such claims for the usefulness of chelation therapy to be controversial, and tend to dismiss out of hand the chance that they might just possibly be accurate.

Prevention and treatment of degenerative diseases
Although chelation therapy for prevention and treatment of degenerative circulatory diseases is practiced by hundreds of medical doctors in the USA and Europe, it remains controversial, inasmuch as it is misunderstood, its use being grossly underinvestigated by mainstream medicine except in treating a narrow range of conditions such as lead and other heavy metal toxicity or acute hypercalcaemia (increased calcium levels in the blood). Ironically, as will be explained in later chapters, it was the medical use of chelation therapy in removing toxic metals which first led to the discovery of its hugely beneficial 'side-effects' of dramatically enhanced circulatory function.

Those doctors who have examined chelation therapy in action and who have seen its outstanding results in preventing and reversing so many degenerative diseases, usually change rapidly from critics to supporters of this essentially safe system.

Imagine someone (a loved one, friend, a patient if you are a physician, or even yourself) being in great pain, or being virtually disabled, as a result of chronic circulatory dysfunction. It might be that there is so much narrowing of the blood vessels to the heart muscle itself that any exertion would be enough to produce the agony of angina, a fist-like gripping in the chest, accompanied by severe pain, a vice-like pressure, gasping for breath and almost total helplessness. Or it might be that the circulation to the legs is so impeded that taking just a few steps across the room brings on cramp-like gripping of the muscles of the lower leg, or severe aching of the upper leg, or both. These symptoms can be so severe that only a few steps can be taken before stopping is imperative while the circulation trickles through and the cramp eases (often taking several minutes), followed by a few more staggering steps as the cycle of intermittent claudication repeats itself. Or it might be that the abilities to function at all, perhaps to speak or to use one or other limb, or even to be able to think rationally, have been largely lost due to impeded circulation to the brain.

Imagine any one of these catastrophes and consider what options remain open to the person facing this hell.

What choices are there?
Chelation is one. In several hundreds of thousands of cases such as those briefly listed above, chelation therapy has helped to restore normal function.

It does not always do so, damage may be too severe and irreversible. But it offers a chance for a very safe form of intervention which can often take the person involved to the stage where surgery and increased medication become unnecessary and where effective long-term preventive methods, including exercise and dietary strategies, can be introduced.

Is chelation natural?
Given the nature of the damage which has already taken place in such conditions, of the dangers which apply and of the emergency status existing in many such cases, it is as natural an option as is likely to be found, and is certainly the safest.

What does medicine have to offer?
Many of the problems listed above relate specifically to obstruction, to the impeding of the flow of blood, often caused directly by the presence of concretions in the lining of major arteries.

Drugs can certainly help, but frequently at the cost of severe side-effects, and none address the causes of the problem, thus leaving the likelihood of the development of further disasters. Certainly there are now a host of drugs of varying degrees of effectiveness, all of which have major side-effects and some of which, while reducing the risks of the patient dying from the particular circulatory problem, actually increase the risks of their dying from other causes (see EDTA: how it works and what it does).

Surgery?
Bypass and other interventions may be possible. These methods (see EDTA: how it works and what it does) help some but not all, and most are risky in themselves or have major drawbacks and few can do anything for brain function if this is the area of the body most affected.

Without question modern surgeons have evolved amazingly skilful techniques, including the following:

  • Balloons are carefully threaded into an appropriate artery before being inflated in order to compress the concretions, thus making more space through which the blood can flow.
  • Alternatively, instead of a balloon, a minute laser might be threaded along the artery to the place where there are concretions so that these can be 'blasted and burned' away.
  • By means of the similar insertion of a minute, high-power drill or cutting instruments, the obstruction is partially chiseled or cut away.
  • There is perhaps the choice of the grafting of veins from other regions of the body, or use of those donated by animals or manufactured from special plastics, by which means the circulatory obstruction may be bypassed.

It is against the considerable known risks and variable and often very short-lived benefits - and of the limited success rate - which most of these methods offer, that we should measure the 'naturalness' or otherwise of a series of gentle infusions into the bloodstream of a synthetic amino acid, EDTA (ethylene-diamine-tetra-acetic acid).

This was initially thought to 'lock on' to the calcium cementing material which binds these concretions together and, by removing it from the scene, to allow the absorption of the rest of the material in the concretion (cholesterol, etc.). This somewhat simplistic picture of what happens has since been replaced by more recent research (described in Chapters 2, 3, 4 and 5), which explains a scientifically more acceptable concept of just how the improvements seen in chelation therapy actually do take place. It was originally thought that as well as leaching out calcium from atheromatous deposits, chelation therapy removed ionic calcium from cells in which it should not be present, thus reducing the chances of local arterial muscle spasms, increasing the free flow of tissue-enhancing, nutritive-rich blood. These benefits are certainly often apparent after chelation therapy, even if the precise mechanisms are not as simple as those which pioneer chelation therapists imagined.

What is known is that once atheromatous concretions lose the calcium which bind them, after a series of chelation infusions, the innate natural defence mechanisms of the body aided by dietary and exercise methods where appropriate, safely take over the removal of the remaining debris which is impeding the blood flow.

Diet and exercise
For many, these can certainly offer help in the long term and should be included whatever else is done (drugs, surgery or chelation), but may not offer the speedy result needed. The exercise element may also be virtually impossible for anyone with intermittent claudication and out of the question, or at best extremely difficult, for someone with cerebral ischaemia or who has had a stroke.

Chelation therapy (combined where possible with dietary and exercise strategies, and by means of mechanisms which will be discussed in later chapters) encourages the circulatory obstructions to be dissolved by the body's own efforts after the concrete binding the blocking material has been dissolved and removed.

Without doubt it would be better to use totally natural methods such as exercise and preventive nutritional approaches. But even if the person so affected were able to comply with the strenuous demands for compliance in such a programme there might not be time to do this before time ran out. Compromise as to what is totally 'natural' would seem to be a small price to pay if the method chosen is safe and is used as part of a comprehensive approach which not only attempts to restore normality to the circulation, but to ensure prevention of any recurrence.

Before chelation infusion therapy is started a detailed study should be made of the patient to ensure that this is an appropriate approach to the problem(s) of the individual.

A full medical case history and examination is the first prerequisite, including a comprehensive personal and family history detailing all aspects of previous health problems and current status. Questions relating to diet, habits, emotional status, exercise, stress levels and a detailed listing of symptoms is part of this. A full physical examination is also required, most notably of all aspects of the circulatory and respiratory systems.

An electrocardiogram and chest X�ray might be required as well as a number of blood tests. Exercise tolerance tests may be used to see just how the functioning of the heart, lungs and circulation responds to activity. A commonly used procedure, before chelation therapy is started, and of major importance in establishing a 'before' picture of circulatory efficiency, is the use of what is known as bi�directional Doppler (sound wave) examination.

Doppler test
This is a painless, non�invasive use of sound waves (ultrasonic) which is used to investigate six major arterial sites which relate to circulation to the brain, as well as eight sites which relate to circulation to the legs. The Doppler equipment gives readings which tell the doctor running the tests three important pieces of information at each site:  

    1. It shows whether there is any turbulence which could relate to breakaway deposits of plaque, etc., which could be involved in production of a stroke.

    2. It checks for any signs of capillary hardening in the brain, often associated with memory loss and age related brain changes.

    3. The major arteries are assessed for obstructions to normal flow of blood which could relate to over�burdened heart function or deficient circulation to the legs.

This sound wave testing takes about an hour and all findings are recorded on charts so that later tests can be compared. This is also an excellent way for the patient to appreciate visually the degree of current circulatory difficulty.

Thermography
Use of thermographically (heat) sensitive film allows areas of the body which are not receiving their full circulatory servicing to be photographed as a record which can be compared with the same region after treatment.

Blood tests
Among other tests, an initial one is performed (not for people with diabetes) after overnight fasting (14 hours without food). This test is usually done around mid�morning, the last food (or coffee or sugar) having been consumed around 9 pm the previous night. The fasting blood test gives an accurate idea of cholesterol levels as well as other key markers. Periodic monitoring of blood levels of cholesterol and other elements (giving evidence of levels of blood fats, carbohydrates, whether or not there is anaemia, infection, immune system problems, liver or kidney dysfunction, etc.) is made during the chelation treatment which can last for some months, with two or three infusions per week.

Depending upon the condition of the patient a blood sample may be required before each treatment, or periodically.

Urine test
A 24�hour sample is required for assessment of normal urinary output of creatinine, a key guide as to kidney status. A periodic assessment is made of the creatinine levels of the urine as the series of chelation treatments progress, but this does not require collection of 24�hour samples. As with blood testing, the frequency of urine testing during a series of chelation infusions will vary, depending on the nature of the problem being treated and the health of the patient.

If there is any evidence that the kidneys could not be expected to deal efficiently with the elimination of EDTA during infusion, then the treatment series would be delayed or stopped until this factor had been dealt with appropriately. As we will see in a description of important research by Doctors McDonagh, Rudolph and Cheraskin later in this chapter, kidney dysfunction is often capable of being normalized by EDTA chelation therapy

Diet and other tests
A computerized dietary analysis (based on the filling in of lengthy questionnaires) of what the patient eats is often required so that comprehensive dietary and supplementation advice can be given to the person being chelated, to complement the treatment.

In addition, saliva, sweat and faeces may need to be tested for a variety of reasons, including assessment of what the patient's current metabolic and nutrient status is, how well foods are being digested and absorbed, etc. Whether such tests are needed will depend upon the individual problems being dealt with.

Hair analysis
This non�invasive and inexpensive method is also sometimes used to provide an accurate indication of heavy metal toxicity as well as to give some idea of the current mineral status of the body. The findings from this and the other tests allow the doctor in charge to decide just what balance of minerals should be added to the basic EDTA infusion solution in order to obtain the best results.

EDTA treatment
Once it has been established that there is a problem which could benefit from EDTA infusion, a series of treatments are scheduled, either two or three times per week. Most chelation centers treat patients in a group setting.

A large room with appropriate seating (usually comfortable recliners) is all that is needed (not unlike a hairdressing or beauty salon). There are several advantages to this approach:  

    1. The mutual support of people having the same procedure is reassuring and encouraging. There will almost always be someone present who has had a number of infusions and who can give a personal account of what to expect.

    2. The costs can be reduced, since fewer supervisory staff are required if patients are grouped together in this way.

    3. During the 3 1/2 hours of the infusion the patient can read, doze, chat, watch TV, listen to a pep talk on diet or exercise from a clinician (this is a truly 'captive audience').

The infusion itself involves the insertion into a vein (usually in the hand or forearm, but sometimes the lower leg) of a needle which is attached to the container (hung on an adjustable stand), from which is drip fed around half a liter of fluid over the 3 1/2 hours' duration of each treatment. This liquid usually contains 2 to 3 grams of EDTA and whatever additional minerals the doctor has decided will best help achieve a balanced blood content.

EDTA mixture
Among the other substances often placed in solution with the EDTA are a complex of B vitamins, vitamin C, magnesium (extremely useful for cardiovascular health) and heparin (an anti�coagulant, enough of which is sometimes used just to prevent any clotting at the injection site). Cranton suggests (Cranton and Frackelton, 1982) that since magnesium is a natural calcium antagonist and also the ion least likely to be removed by EDTA (see Chapter 4), and that it is relatively deficient in many people with cardiovascular and circulatory problems, it should be supplied with the chelation process. He suggests that the best way to do this is to use magnesium�EDTA, which would provide an efficient delivery system and thereby increase magnesium stores in the body.

When the infusion is being performed, the arm is kept stable as a rule by being taped to a padded board which rests on a cushion for comfort. It is usually quite possible (although it is not encouraged) for the patient to move around freely during treatment (to visit the toilet, for example) as long as the mobile infusion is wheeled alongside.

The rate at which the EDTA solution is dripped into the bloodstream can be varied but usually it is at a rate of one drop per second.

As a general rule, two, but sometimes three, treatments are given each week, and a total of anything from 20 (for relatively mild problems) to 30 infusions in all comprise one complete series.

On a number of occasions (sometimes at each visit) blood and urine testing (as well as other tests) may be carried out to ensure that kidney and other functions are operating sufficiently well to cope with the EDTA detoxification. This is obviously more important in elderly patients or anyone with compromised kidney function. In some instances where a great deal of circulatory pathology exists, follow�up series of chelation infusions might be encouraged, with many people showing benefits after up to 100 infusions.

The EDTA is eliminated from the body, 95 per cent via the kidneys and 5 per cent via the bile, along with the toxic metals and free ionic calcium which it has locked on to in its transit through the circulatory system.

In hospital settings, EDTA infusions have in the past been given daily for up to five days, followed by a two�day rest period for the kidneys. This protocol is now discouraged by the American medical group with the most experience of chelation, the American Academy of Medical Preventics.

Toxicity and cautions

General toxicity Walker and Gordon (1982) inform us that EDTA is far safer than aspirin, digoxin, tetracyclin, ethyl alcohol or the nicotine from two cigarettes, in equivalent therapeutic doses. EDTA is used in thousands of food products (it is in most canned foods) and its toxicity is known to be extremely low.

In assessing the relative toxicity of a substance a therapeutic index is established. Firstly, the amount of the substance which would prove lethal to half the animals in an experimental setting is discovered by the gruesome process of increasing their intake until half of them die. This is the LD�50 measurement (LD for lethal dose). When this amount is divided by the amount required for a therapeutic effect we end with a number which is the therapeutic index.

The LD�50 of EDTA is 2000 milligrams per kilo of body weight, whether taken orally or intravenously. In comparison aspirin has a toxicity equal to 558 milligrams per kilo of body weight. So in general there is no need for concern as to general toxicity with EDTA usage, whether by mouth (see Chapter 9) or directly into the blood.

Kidney toxicity
In the early 1950s several deaths occurred from nephrotoxicity after EDTA treatment. At that time the dosage used was around 10 grams per infusion, whereas the recommended dose now adays is 3 grams.

Halstead (1979) states:  

    The problem in EDTA nephrotoxicity is based upon two fundamental principles of toxicology: dosage and route of administration. Dosage is concerned with both the amount administered and the rate of administration, or the time period in which the EDTA is given.

It appears that toxicity for the kidneys may relate directly to too large a dose infused at too fast a rate. In general, if no more than 3 grams is infused in any 24�hour period (diluted with 500 ml sterile Lactated Ringer's solution or-except in the case of diabetes-5 per cent dextrose solution), with a 24�hour rest period between chelation infusions (2�3 per week) and if the infusion of these 3 grams (less than 50 milligrams per kilo of body weight) is timed to take around three hours, little if any danger exists of producing toxicity for the kidneys.

Indeed, research has shown that in general chelation therapy improves kidney function, particularly if any impairment to these vital organs relates to circulatory problems.

Improved kidney function after EDTA
McDonagh, Rudolph and Cheraskin (1982d) have investigated the alleged toxicity of EDTA in relation to kidney function and their results are worth some consideration.

They examined the results of treating 383 people with a variety of chronic degenerative disorders (primarily occlusive arterial disease) with EDTA chelation therapy (plus supportive multivitamin/mineral supplementation) for 50 days.

The measurement of the levels of creatinine in the blood is commonly used in medicine as a guide to kidney efficiency.

Creatinine is the end breakdown product of muscle activity which is cleared from the body by filtration through the normal kidney. The levels found in the bloodstream are known to correlate well with the rate and efficiency of clearance, giving a simple way of judging kidney function. The researchers made specific measurements of the levels of creatinine in the blood of these patients at the first visit (fasting levels) and then gave 10 infusions of 3 grams of EDTA in a solution of 1000 cc normal saline with an interval of five days between each infusion (supplementation was also given). After this the serum creatinine was again assessed.

They found that a very interesting balancing effect could be seen when the overall picture was revealed, very similar to that noted when cholesterol ratios were examined (see Chapter 4). Those people who initially had low levels of serum creatinine showed a very slight increase; those in the mid�range (normal?) showed no change and those above the mid�range of normal and actually with a creatinine excess (therefore indicating poor clearance by the kidneys) showed a drop towards normal.

Overall the total measurement showed an average decline in serum levels (indicating improved kidney function), but far more significant, according to the judgement of the researchers, is the homoeostatic effect in which � whether high or low to start with � a tendency towards the mid�range (between 0.5 and 1.7 milligrams/decilitre) is observed.

It seems that EDTA therapy may actually improve kidney function if it is applied slowly with normal dosages.

One exception
These researchers make note of one exceptional case amongst nearly 400 patients tested in this way, and the progression of events is worth noting as an example which highlights both the initial concerns which some patients might produce and the long-term benefits of chelation therapy.

This was an 86�year�old female in whom the initial measurement of creatinine was 1.9 mg/dl, which is regarded as abnormally high and therefore indicative of poor kidney function. After starting chelation every five days, a rise was seen in the creatinine levels by day 25 (fifth infusion) to a very unhealthy 3.5 mg/dl. As treatment progressed, it dropped to 2.8 mg/dl by day 60 and had dropped to 1.8 mg/dl by day 100, some time after the course of chelation therapy had finished.

As the researchers point out: 'this emphasizes the need to follow renal function during EDTA therapy, and, one might add, for a while after, as the benefits frequently are not fully manifest before about three months after treatment is over.

Special considerations: age, heavy metals or parathyroid deficiency
If the patient is very elderly, or has low parathyroid activity or is suffering from heavy metal toxicity which is damaging kidney tubules, treatment should be modified to use less EDTA less frequently (once weekly perhaps). Heavy metals damage the kidneys and too rapid infusion can overload them. Heavy metals most likely to produce kidney damage during infusion therapy (if this is done too rapidly, that is) are lead, aluminum, cadmium, mercury, nickel, copper and arsenic.

Renal function tests should always be performed before chelation therapy is started in which serum nitrogen (BUN) and serum creatinine is examined. In any case of significant renal impairment, lower dosage EDTA infusions should be used with extreme caution with suitable periods of rest between.

Too much calcium removed
If, through inexperience or error, there is too rapid an infusion (or too much EDTA used), levels of calcium in the blood can drop rapidly, resulting in cramps, tetany, convulsions, etc. An injection of calcium gluconate will swiftly control such abnormal reactions. This hypocalcaemia reaction is almost unheard of where the guidelines given above are followed as to dosage, speed of infusion and spread of treatments.

Inflammation of a vein
If an infusion into a vein is performed too rapidly, inflammation may occur (thrombophlebitis). This is unlikely in the extreme if guidelines as described above are followed concerning dilution of EDTA with Ringers solution or dextrose solution and slow infusion.

Should the needle carrying the infusion slip, a local soft tissue irritation may develop. This may best be treated with use of alternate hot and cold packs. Supplementation with antioxidant nutrients such as vitamins C and E (make sure of a good source) and the mineral selenium should protect against such an incident.

Care regarding insulin shock and hypoglycaemia
During EDTA infusion it is possible for blood glucose to drop, leading to insulin shock. This is more likely amongst diabetics in whom no dextrose solution should be used. Patients having EDTA infusions are advised to have a snack before or during the three hours plus treatment period. Walker and Gordon (1982) recommend the following strategy:
 

    You should eat something before the three to four hour infusions, but not high�calcium�containing foods such as dairy products. Rather, eat adequate unrefined complex carbohydrates and avoid most sugars, including overripe bananas.

During an infusion they recommend eating fruit.

In diabetic individuals, using zinc�bound insulin involves a risk of too rapid a release of insulin, leading to hypoglycaemia and shock. A rapid introduction of sugar is needed in such an instance and a change in the form of insulin used before further EDTA infusions are tried. Most people with known diabetes find that with chelation therapy their requirement for insulin declines.

Congestive heart failure
If the heart is already unable to cope adequately with movement of fluids, and there is evidence of congestive heart failure (extreme shortness of breath, swollen ankles) and/or if digitalis�like medication is being taken, extreme care is needed over chelation infusions, since EDTA prevents digitalis working adequately. Sodium EDTA would appear to be undesirable in such people as it could increase the fluid retention tendency. However, Halstead is adamant that:

 

    Na2 EDTA does not appear to have any significant deleterious effects in congestive heart patients since the sodium (Na2) is apparently excreted intact with the metal chelate. However, the use of 5 per cent dextrose and water is recommended in such cases.

Short�term side�effects
A number of variable side�effects have been observed with use of intravenous EDTA infusion, including the following:

  • Headaches � which often relate to the same phenomenon discussed above, of low blood sugar. Eating before treatment, or during it, will usually prevent this possibility. It is reported that a common recommendation which prevents 'EDTA�headaches' is that a banana, not overripe, be eaten during the first hour of infusion.

  • Diarrhoca � this unusual side�effect should be treated with rest and a bland diet with plenty of liquids for a day or so. Urinary frequency is common as kidney efficiency improves and a weight loss (from fluid excretion) of 3�5 pounds (1.3�2.2 kg) is common after an infusion if fluid retention was previously evident.

  • Local skin irritation may result and is usually associated with a reduction in zinc and vitamin B6 (pyridoxine). For this reason supplementation of these nutrients is usually suggested during chelation therapy.

  • Nausea or stomach upset may also be related to vitamin B6 deficiency in the less than one patient in 100 receiving chelation therapy who feels this side effect. It is best treated by B6 supplementation, although short-term relief (up to eight hours) from nausea can be achieved by applying thumb pressure to a point two thumb�widths above the wrist crease on either forearm (acupuncture point P6) for a minute or so whenever the symptom is felt.

  • Feeling faint may relate to a drop in blood pressure. It is common for those who start treatment with high blood pressure to see a return to more normal levels. If it were normal to start with, it could drop slightly as well as leading to feelings of faintness on standing after sitting or lying. Treatment is to rest for an hour or so when this happens, ideally with the feet slightly higher than the head. The amino acid tyrosine can safely be supplemented to help restore normal pressure levels if this symptom persists.

  • Fever may develop in a very few people during the day after chelation therapy sessions (approximately one in 5000). Whoever is in charge of the treatment should be told, although the condition normally resolves on its own.

  • Extreme fatigue may be felt in some people and this is usually the result of a general nutrient deficiency in minerals such as magnesium, zinc or potassium. Taking a potassium�rich supplement and/or the regular eating of potassium�rich foods is suggested before and during chelation (grapes, bananas, peaches, potato skins), as this mineral may be removed by the process itself.

  • Pains in the joints are more likely where infusions are frequent (three weekly). An immediate reduction to once weekly is suggested, and also possibly a reduction in dosage of EDTA being used, if strong flu�like aches develop. The symptoms should pass fairly soon if these strategies are adopted.

  • Cramps in the legs are not uncommon (one patient in 20), usually at night. The supplementation of magnesium (either by mouth or in the EDTA infusions) will usually prevent this happening. If it is added to the infusion this could be in the form of magnesium chloride or magnesium sulphate. Such additions also reduce the chance of local skin irritation at the site of the infusion.

Other minor side effects have been reported in the many millions of chelation infusions already given, but all seem to vanish when the therapy is reduced or stopped. As Bruce Halstead states: 'The number of significant untoward reactions is probably less than in any other major therapeutic modality'

Other related articles

Circulatory Obstruction ] Position Paper ]

 

Copyright � 1999-2003 Health & Wellness Inc.